Flavocure Biotech, Inc. — Form D
Flavocure Biotech, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-21. The offering totals $2.0M, of which $215K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-21
- Form: D
- Accession: 0001683168-25-001151
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $215K
- Remaining: $1.8M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2025-02-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538836
Issuer
- Name: Flavocure Biotech, Inc.
- CIK: 0001960342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 701 E PRATT ST, BALTIMORE, MD, 21202
- Phone: 240-381-7329
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Justin Grant | Director | Baltimore, MD |
| Henry Lowe | Director | Baltimore, MD |
| Ngeh Toyang | Director | Baltimore, MD |
| Douglas Liu | Executive Officer | Baltimore, MD |
| Henry Lowe | Executive Officer | Baltimore, MD |
| Ngeh Toyang | Executive Officer | Baltimore, MD |
| Eric Chapman | Promoter | Cumberland, ME |
| David Brooks | Executive Officer | New York, NY |
| Swen Simms | Promoter | Kingston 20, L8 |
| David Traylor | Promoter | Centennial, CO |
| Theresia Toyeng | Promoter | Elkridge, MD |
| Thomas Lang | Executive Officer | Dublin, OH |
| Anthony Deasey | Promoter | Severna Park, MD |
| Saurabh Sewak | Promoter | Winchester, MA |
Other filings by this issuer (1)
More